Sense and nonsense of high-dose cytarabine for acute myeloid leukemia

High-dose cytarabine applied during remission induction or as consolidation after attainment of a complete remission has become an established element in the treatment of adults with acute myeloid leukemia. Recent evidence has challenged the need for these exceptionally high-dose levels of cytarabine. In this review, we present a reappraisal of the usefulness of high-dose cytarabine for acute myeloid leukemia treatment.

• View at Publisher
• View at Pubmed
• View at Scopus
• View at Web of Science